Autopsy report · NCT00266357
Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)
Cause of deathNo reason given
Life of this trial
- 50 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- H. Lundbeck A/S
- Sponsor type
- Industry
- Conditions
- Primary Insomnia
- Interventions
- MK0928, gaboxadol / Duration of Treatment: 6 days for treatment periods (2 days/dose); Placebo / Duration of Treatment: 2 days for screening period
- Participants
- 50
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.